Marker Therapeutics Inc (MRKR)

[Stockdoggy]

I received two copies (one for each account I hold TPIV in) of this letter as well. I thought it was a nice touch to reach out and thank shareholders, and that Mr. Hoang sounded enthusiastic. I particularly appreciated "We must better communicate our value proposition to the capital markets to ensure that Tapimmune is appropriately valued in the marketplace". Also, "We must drive ourselves to become a more efficient organization in the prosecution of our clinical trials so that we achieve every milestone that we set for ourselves." I hope that they can do both...